Trial Profile
Rituximab maintenance treatment in patients with CD20+ B-cell non-Hodgkin's lymphoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Jul 2012
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications B-cell lymphoma; Diffuse large B cell lymphoma; Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 17 Jun 2012 Results for patients with diffuse large B-cell lymphoma presented at the 17th Congress of the European Haematology Association.
- 13 Mar 2009 New trial record.